secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVRx, Inc. (CVRX)
CIK:        0001235912
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001104659-23-002098
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVRx reports preliminary Q4 revenue up ~91-94% YoY; FY2023 guidance $35-38M
---------------------------------------------------------------------------

- Q4 2022 revenue $7.0-7.1M (+91-94% YoY); U.S. heart failure revenue $5.9M.
- FY2022 revenue $22.3-22.4M (+71-72%); 106 active implanting centers (up from 91).
- Cash and equivalents $106M as of Dec 31, 2022; 26 U.S. sales territories.
- FY2023 guidance: revenue $35-38M, gross margin 78-79%, operating expenses $76-80M.
- Q1 2023 revenue expected $7.1-7.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1235912/000110465923002098/0001104659-23-002098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1235912/000110465923002098/tm232626d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-002098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer